2022 American Transplant Congress
Consent to Organ Offers from Public Health Service Increased Risk Donors Decreases Time to Transplant and Waitlist Mortality
University of California, San Francisco, San Francisco, CA
*Purpose: The Public Health Service Increased Risk designation identified organ donors at increased risk of transmitting hepatitis B, hepatitis C, and human immunodeficiency virus. Despite…2022 American Transplant Congress
Single Center Experience with “Extreme” Acute Kidney Injury Deceased Donor Kidneys
Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC
*Purpose: Although many centers will consider transplanting kidneys from deceased donors (DD) with mild acute kidney injury (AKI), a markedly elevated terminal serum creatinine (tSCr)…2022 American Transplant Congress
Use of Organ-Specific Chimeric Antigen Receptor Promotes Liver Recruitment of Regulatory T Cells
1King's College London, London, United Kingdom, 2Quell Therapeutics, London, United Kingdom
*Purpose: Owing to their potent immune-modulatory properties, regulatory T cells (Tregs) have been explored as novel cell therapy to induce allograft tolerance, with first clinical…2022 American Transplant Congress
Early Experience with Varicella Vaccination in Pediatric Heart Transplant Recipients
The Hospital of Sick Children, Toronto, ON, Canada
*Purpose: International consensus guidelines to vaccinate children after transplant with varicella (VZV) vaccine exclude heart recipients due to insufficient evidence for safety, seroconversion rate, and…2022 American Transplant Congress
Outcomes in Elderly Black Renal Transplant Recipients Receiving Basiliximab Induction and Early Steroid Withdrawal
University of Maryland Medical Center, Baltimore, MD
*Purpose: Black renal transplant recipients (RTR) carry a higher risk of rejection (BPAR) and graft loss due to immunologic and non-immunologic factors. Lymphocyte depleting induction…2022 American Transplant Congress
A More Equitable Transplant Evaluation: What Patient-Level Factors Impact Time to Kidney Transplant Evaluation Completion?
Houston Methodist, Houston, TX
*Purpose: The kidney transplant evaluation process can take months or years to complete depending on patient health status and level of engagement. This study examines…2022 American Transplant Congress
Post-Xenotransplant Antibody Specificities Against Swine, Monkey and Human Leukocyte Antigens in Highly Sensitized Nonhuman Primate Model
Surgery, Duke Transplant Center, Durham, NC
*Purpose: Xenotransplantation has been proposed as a bridge to transplant for allosensitized patients. However, the potential of xenotransplantation to broaden HLA allosensitization due to MHC…2022 American Transplant Congress
Financial Barriers Experienced During the Transplant Process by Caregivers of Children with End Stage Kidney Disease
*Purpose: Known socioeconomic disparities in transplant referral and evaluation exist in adults with end-stage kidney disease, but little is known about the financial burden that…2022 American Transplant Congress
Transplant Centers That Assess Frailty as Part of Clinical Practice Have Better Outcomes
*Purpose: Frailty predicts adverse post-kidney transplant (KT) outcomes, yet impacts of frailty assessments on center-level outcomes remain unclear. We tested whether transplant centers assessing frailty…2022 American Transplant Congress
An In Depth Assessment of Unsuccessful DCD Donor Procurement Attempts: Areas for Improvement
Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX
*Purpose: DCD donors are a key way to expand allograft supply but an aggressive strategy of pursuing DCD liver allografts is associated with significant number…
- « Previous Page
- 1
- …
- 169
- 170
- 171
- 172
- 173
- …
- 1683
- Next Page »